Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Odile Launay

Showing results (191-200 of 305) with videos related to

Pageof 31
Sort By:
Frontiers in Immunology|May 21, 2021
Antibodies Elicited by the <i>Shigella sonnei</i> GMMA Vaccine in Adults Trigger Complement-Mediated Serum Bactericidal Activity: Results From a Phase 1 Dose Escalation Trial Followed by a Booster ExtensionFrancesca Micoli, Omar Rossi, Valentino Conti, et al.
Journal of Medical Virology|May 29, 2023
Impact of corticosteroids use on midterm sequelae in survivors of COVID-19 admitted to hospital: A prospective cohort studyNathalie Gault, Delphine Bachelet, Cédric Laouénan, et al.
AIDS (London, England)|July 16, 2019
Long-term safety and vaccine-induced seropositivity in healthy volunteers from HIV vaccine trialsChristine Durier, Corinne Desaint, Jean-Daniel Lelièvre, et al.
AIDS (London, England)|October 6, 2018
CD4+ cell count recovery after combined antiretroviral therapy in the modern combined antiretroviral therapy eraHélène Roul, Murielle Mary-Krause, Jade Ghosn, et al.
Vaccine|June 15, 2013
Control of humoral immunity and auto-immunity by the CXCR4/CXCL12 axis in lupus patients following influenza vaccineOdile Launay, Stéphane Paul, Amélie Servettaz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 21, 2015
Incidence of herpes zoster in HIV-infected adults in the combined antiretroviral therapy era: results from the FHDH-ANRS CO4 cohortSophie Grabar, Pierre Tattevin, Hana Selinger-Leneman, et al.
Human Vaccines & Immunotherapeutics|October 3, 2013
Clinical validation of IFNγ/IL-10 and IFNγ/IL-2 FluoroSpot assays for the detection of Tr1 T cells and influenza vaccine monitoring in humansAnne Chauvat, Nadine Benhamouda, Alain Gey, et al.
AIDS (London, England)|July 14, 2010
Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: a phase 2 placebo-controlled ANRS trialDominique Salmon-Céron, Christine Durier, Corinne Desaint, et al.
The Lancet. Infectious Diseases|August 11, 2015
Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trialDavid Rey, Lionel Piroth, Marie-Josée Wendling, et al.
The Journal of Infectious Diseases|August 17, 2019
Immunogenicity and Safety of 3 Formulations of a Respiratory Syncytial Virus Candidate Vaccine in Nonpregnant Women: A Phase 2, Randomized TrialTino F Schwarz, Roderick A McPhee, Odile Launay, et al.
Pageof 31

Showing results (191-200 of 305) with videos related to

Sort By:
Pageof 31
Frontiers in Immunology|May 21, 2021
Antibodies Elicited by the <i>Shigella sonnei</i> GMMA Vaccine in Adults Trigger Complement-Mediated Serum Bactericidal Activity: Results From a Phase 1 Dose Escalation Trial Followed by a Booster ExtensionFrancesca Micoli, Omar Rossi, Valentino Conti, et al.
Journal of Medical Virology|May 29, 2023
Impact of corticosteroids use on midterm sequelae in survivors of COVID-19 admitted to hospital: A prospective cohort studyNathalie Gault, Delphine Bachelet, Cédric Laouénan, et al.
AIDS (London, England)|July 16, 2019
Long-term safety and vaccine-induced seropositivity in healthy volunteers from HIV vaccine trialsChristine Durier, Corinne Desaint, Jean-Daniel Lelièvre, et al.
AIDS (London, England)|October 6, 2018
CD4+ cell count recovery after combined antiretroviral therapy in the modern combined antiretroviral therapy eraHélène Roul, Murielle Mary-Krause, Jade Ghosn, et al.
Vaccine|June 15, 2013
Control of humoral immunity and auto-immunity by the CXCR4/CXCL12 axis in lupus patients following influenza vaccineOdile Launay, Stéphane Paul, Amélie Servettaz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 21, 2015
Incidence of herpes zoster in HIV-infected adults in the combined antiretroviral therapy era: results from the FHDH-ANRS CO4 cohortSophie Grabar, Pierre Tattevin, Hana Selinger-Leneman, et al.
Human Vaccines & Immunotherapeutics|October 3, 2013
Clinical validation of IFNγ/IL-10 and IFNγ/IL-2 FluoroSpot assays for the detection of Tr1 T cells and influenza vaccine monitoring in humansAnne Chauvat, Nadine Benhamouda, Alain Gey, et al.
AIDS (London, England)|July 14, 2010
Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: a phase 2 placebo-controlled ANRS trialDominique Salmon-Céron, Christine Durier, Corinne Desaint, et al.
The Lancet. Infectious Diseases|August 11, 2015
Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trialDavid Rey, Lionel Piroth, Marie-Josée Wendling, et al.
The Journal of Infectious Diseases|August 17, 2019
Immunogenicity and Safety of 3 Formulations of a Respiratory Syncytial Virus Candidate Vaccine in Nonpregnant Women: A Phase 2, Randomized TrialTino F Schwarz, Roderick A McPhee, Odile Launay, et al.
Pageof 31